Defending the ‘middlemen’ in the battle on drug prices

2018-05-15 | The Hill: Healthcare Policy

Pharmacy benefit managers (PBM) — the “middlemen” in drug price negotiations — are under attack, and, for the past 15 years, Mark Merritt has been the point man in charge of defending them.Merritt, who recently underwent open-heart surgery, is...

Link to document